183 | Pericyte-like adipose mesenchymal stem cells as a tool for blood-retinal barrier repair
Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale · 31.03.2026 · 99 (s1)
DOI: 10.4081/jbr.2026.15435 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale, online erschienen am 31.03.2026. Verfasst von Società Italiana di Biologia Sperimentale. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
In the last few decades, adipose-derived mesenchymal stem cells (ASCs) have been widely investigated in the field of regenerative medicine because of their multipotent differentiation ability. For this reason, they represent a valuable tool to treat various pathologies, including eye diseases such as diabetic retinopathy (DR). DR is characterized by massive pericyte loss, leading to altered interactions between endothelial cells and pericytes, and impairment of the blood-retinal barrier (BRB). Previous our studies showed a successful pericyte-like differentiation of ASCs (P-ASCs) using a culture medium specifically designed for pericytes. To mimic the altered microenvironment of a diabetic eye, samples of P-ASCs were cultured in high glucose conditions, where they induced increased levels of anti-inflammatory cytokines as well as decreased expression of pro-inflammatory cytokines. Moreover, co-cultures of P-ASCs and human retinal endothelial cells showed an increased endothelial expression of junction proteins (vascular endothelial-cadherin and zonula occludens-1), suggesting an improved BRB integrity, as also indicated by higher values of trans-endothelial electrical resistance. In the present work, we tested the effects exerted by human-derived P-ASC that were intravitreally injected in a streptozotocin (STZ)-induced diabetic rat model. To this aim, after 3 weeks from P-ASC injections, retinas were flat mounted and processed for subsequent experimental procedures. Immunostaining for human nuclear antigen (HNA) showed that positive cells, consisting only of those injected, survived and were mostly found in perivascular regions, thus indicating P-ASCs ability to reach and attach to retinal blood vessel walls. In addition, these injected P-ASCs were characterized by strong alpha-smooth muscle actin (α-SMA) immunostaining, confirming their pericyte-like differentiation even after injections. Evans Blue staining showed that in healthy animals the dye was confined to the vascular lumen, whereas several focal points of blood extravasation could be detected in STZ rats, as occurs after BRB breakdown. On the contrary, intravitreal injections of P-ASCs in STZ rats markedly reduced the retinal extravasation of Evans Blue dye, indicating reduced plasma protein leakage in the retinal parenchyma and improved BRB function. It can be concluded that P-ASCs may represent a valuable tool to develop therapeutic strategies to counteract BRB disruption in cases of diabetic retinopathy.
Zitieren
APA
Sperimentale, S. I. D. B. (2026). 183 | Pericyte-like adipose mesenchymal stem cells as a tool for blood-retinal barrier repair. Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale, 99(s1). https://doi.org/10.4081/jbr.2026.15435
Vancouver
Sperimentale SIDB. 183 | Pericyte-like adipose mesenchymal stem cells as a tool for blood-retinal barrier repair. Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale. 2026;99(s1). doi:10.4081/jbr.2026.15435
BibTeX
@article{Sperimentale2026,
author = {Sperimentale, Società Italiana di Biologia},
title = {183 | Pericyte-like adipose mesenchymal stem cells as a tool for blood-retinal barrier repair},
journal = {Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale},
year = {2026},
volume = {99},
number = {s1},
doi = {10.4081/jbr.2026.15435}
}
EUVIMED